Obermatt

Flags

Financial distress

Bioventus

NSQ:BVS · US09075A1088
Health Care Equipment & SuppliesMedium

360

97
EV / EBIT89
Price / Owner Earnings52
Owner Earnings Yield86
Dividend Yield1
Price/Sales78
EV / Gross Profit87
Price/Book41
Return on Capital71
Cash Return on Capital79
Return on Equity90
EBIT Margin60
Gross Profitability88
Cash Conversion91
Accruals83
Owner Earnings Margin66
Sales growth51
Profit Growth57
Long-Term EPS Growth67
Owner Earnings Growth90
Reinvestment52
Price momentum85
Debt load24
Refinancing69
Debt Payback38
Liquidity65
Analyst ratings74
Opinion Changes50
Price Target Upside91
Market mood18
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Bioventus generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees944
ISINUS09075A1088
Last UpdateApr 2, 2026
Themes
Biomedical EngineeringPain ManagementNeurologyOsteoporosisOrthopaedicsSurgeryHealth Care

Description

Bioventus Inc. (‘Bioventus’), a global medical device company, focuses on helping patients recover and live life to the fullest by relieving pain and addressing musculoskeletal challenges through a diverse portfolio of high-quality, innovative, and c…

Analysis

Hidden champion

Bioventus Inc. fits the profile of a hidden champion, yet the market has not awarded it the premium its quality earns.

On valuation, the picture is attractive. The owner-earnings multiple stands at 12.5×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around -0% a year, against analyst forecasts of 11%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is stretched. The company scores 18/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
56
2023202420252026

All-time high

82

Jan 2023

All-time low

15

Jan 2024

Average rank

52

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
78
65
83
79
Price/Earnings
56
73
87
96
Price/Book
41
55
71
43
Dividend Yield
1
1
1
1
Value (overall)
55
63
88
81

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bioventus with its peers
Sanara MedTech
NAQ:SMTI
52
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Treace Medical Concepts
NSQ:TMCI
28
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Orthofix
NSQ:OFIX
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
CVRx
NSQ:CVRX
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Avanos Medical
NYQ:AVNS
48
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →